These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31675271)
1. Impact of new-onset diabetes on clinical outcomes after ST segment-elevated myocardial infarction. Seo JY; Park JS; Seo KW; Yang HM; Lim HS; Choi BJ; Choi SY; Yoon MH; Hwang GS; Tahk SJ; Shin JH Scand Cardiovasc J; 2019 Dec; 53(6):379-384. PubMed ID: 31675271 [No Abstract] [Full Text] [Related]
2. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents. Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033 [TBL] [Abstract][Full Text] [Related]
3. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease. Perera D; Crake T; Lee V Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315 [TBL] [Abstract][Full Text] [Related]
4. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus. Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognosis for different onset stage of cardiogenic shock secondary to ST-segment elevation myocardial infarction. Qiao S; Zhang J; Kong Z; Wu H; Gu R; Zheng H; Xu B; Wei Z BMC Cardiovasc Disord; 2020 Jun; 20(1):302. PubMed ID: 32560702 [TBL] [Abstract][Full Text] [Related]
6. Newly diagnosed and previously known diabetes mellitus and short-term outcomes in patients with acute myocardial infarction. Tian L; Wei C; Zhu J; Liu L; Liang Y; Li J; Yang Y Coron Artery Dis; 2013 Dec; 24(8):669-75. PubMed ID: 24212264 [TBL] [Abstract][Full Text] [Related]
7. In-hospital and 30-day major adverse cardiac events in patients referred for ST-segment elevation myocardial infarction in Dhaka, Bangladesh. Akhtar Z; Aleem MA; Ghosh PK; Islam AKMM; Chowdhury F; MacIntyre CR; Fröbert O BMC Cardiovasc Disord; 2021 Feb; 21(1):85. PubMed ID: 33568047 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: a prospective cohort study. Li N; Zhou J; Chen R; Zhao X; Li J; Zhou P; Liu C; Chen Y; Wang Y; Song L; Yan S; Zhao H; Yan H Cardiovasc Diabetol; 2023 Jun; 22(1):151. PubMed ID: 37365608 [TBL] [Abstract][Full Text] [Related]
10. Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation. Lovic MB; Djordjevic DB; Tasic IS; Nedeljkovic IP Hellenic J Cardiol; 2018; 59(4):226-231. PubMed ID: 29452307 [TBL] [Abstract][Full Text] [Related]
11. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention. Byun JK; Choi BG; Rha SW; Choi SY; Jeong MH; Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681 [TBL] [Abstract][Full Text] [Related]
12. Improved long-term survival for diabetic patients with surgical versus interventional revascularization. Kurlansky P; Herbert M; Prince S; Mack MJ Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668 [TBL] [Abstract][Full Text] [Related]
13. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction. Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389 [TBL] [Abstract][Full Text] [Related]
14. Optimized Prognosis Assessment in ST-Segment-Elevation Myocardial Infarction Using a Cardiac Magnetic Resonance Imaging Risk Score. Stiermaier T; Jobs A; de Waha S; Fuernau G; Pöss J; Desch S; Thiele H; Eitel I Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29122844 [TBL] [Abstract][Full Text] [Related]
15. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction. Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724 [TBL] [Abstract][Full Text] [Related]
16. Impact of the Japanese Version of High Bleeding Risk Criteria on Clinical Outcomes in Patients with ST-segment Elevation Myocardial Infarction. Konoma S; Sakakura K; Jinnouchi H; Taniguchi Y; Tsukui T; Hatori M; Tamanaha Y; Kasahara T; Watanabe Y; Yamamoto K; Seguchi M; Fujita H J Atheroscler Thromb; 2024 Jun; 31(6):917-930. PubMed ID: 38092385 [TBL] [Abstract][Full Text] [Related]
17. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry. Pimor A; Auffret V; Didier R; Delaunay R; Filippi E; Hacot JP; Saouli D; Rouault G; Druelles P; Bot E; Coudert I; Boulanger B; Le Guellec M; Boulmier D; Leurent G; Bedossa M; Gilard M; Le Breton H Arch Cardiovasc Dis; 2018 Nov; 111(11):656-665. PubMed ID: 29229216 [TBL] [Abstract][Full Text] [Related]
18. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction). Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry. Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E; Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193 [TBL] [Abstract][Full Text] [Related]
20. Association of lymphocyte-to-monocyte ratio with the long-term outcome after hospital discharge in patients with ST-elevation myocardial infarction: a retrospective cohort study. Cai M; Liang D; Gao F; Hong X; Feng X; Yang Y; Wu S; Huang W Coron Artery Dis; 2020 May; 31(3):248-254. PubMed ID: 31658149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]